找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy of Cancer; An Innovative Treatm Yoshiyuki Yamaguchi Book 2016 Springer Japan 2016 biomarkers.cancer vaccine.immune checkpoint

[復(fù)制鏈接]
查看: 48450|回復(fù): 54
樓主
發(fā)表于 2025-3-21 19:27:19 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Immunotherapy of Cancer
副標(biāo)題An Innovative Treatm
編輯Yoshiyuki Yamaguchi
視頻videohttp://file.papertrans.cn/463/462306/462306.mp4
概述Summarizes the rationale, present status, and future perspective for cancer immunotherapy.Provides comprehensive knowledge of the mechanism of cancer immunotherapy.Enriches the reader’s understanding
圖書封面Titlebook: Immunotherapy of Cancer; An Innovative Treatm Yoshiyuki Yamaguchi Book 2016 Springer Japan 2016 biomarkers.cancer vaccine.immune checkpoint
描述.This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy.?This innovative therapy has been investigated worldwide as the fourth line of cancer treatment after the standard treatments of surgery, chemotherapy, and radiotherapy. The progress in fundamental understanding of tumor immunology and the recent advances in clinical trials have opened new avenues with a cancer vaccine in 2010 and immunocheckpoint modulation in 2011, with their approval already granted in the United States. Today, there are no doubts, even among experts in cancer chemotherapy and radiotherapy, thatthe immune system plays a vital role in tumor eradication. Following American approval,?many clinical trials of cancer immunotherapy are being conducted..?With this book the reader will readily understand th
出版日期Book 2016
關(guān)鍵詞biomarkers; cancer vaccine; immune checkpoints; tumor immunology; cancer immunotherapy
版次1
doihttps://doi.org/10.1007/978-4-431-55031-0
isbn_softcover978-4-431-56639-7
isbn_ebook978-4-431-55031-0
copyrightSpringer Japan 2016
The information of publication is updating

書目名稱Immunotherapy of Cancer影響因子(影響力)




書目名稱Immunotherapy of Cancer影響因子(影響力)學(xué)科排名




書目名稱Immunotherapy of Cancer網(wǎng)絡(luò)公開度




書目名稱Immunotherapy of Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Immunotherapy of Cancer被引頻次




書目名稱Immunotherapy of Cancer被引頻次學(xué)科排名




書目名稱Immunotherapy of Cancer年度引用




書目名稱Immunotherapy of Cancer年度引用學(xué)科排名




書目名稱Immunotherapy of Cancer讀者反饋




書目名稱Immunotherapy of Cancer讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:50:05 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:32:58 | 只看該作者
Yoshiyuki Yamaguchi M.D., Ph.D.al surgeon. Expertise in in- direct ophthalmoscopy, scleral depression, and contact lens biomicroscopy serves as a basis for observing the peripheral retina. These observations are then re- corded on fundus drawing paper and the Tolentino vitreo-retinal chart. This or- derly sequence of skills allow
地板
發(fā)表于 2025-3-22 05:24:00 | 只看該作者
al surgeon. Expertise in in- direct ophthalmoscopy, scleral depression, and contact lens biomicroscopy serves as a basis for observing the peripheral retina. These observations are then re- corded on fundus drawing paper and the Tolentino vitreo-retinal chart. This or- derly sequence of skills allow
5#
發(fā)表于 2025-3-22 12:15:12 | 只看該作者
Junichi Sakamoto M.D., Ph.D., F.A.C.S.,Michitaka Honda M.D., Ph.D.,Toru Aoyama M.D.ems so far from the surgery we perform in the operating room..With the advent of the . techniques, we learned to be more precise and respectful of anatomy..We learned from Daniel, Pálházi, and Saban the surgical anatomy for .. They described numerous anatomical structures and important landmarks suc
6#
發(fā)表于 2025-3-22 13:47:33 | 只看該作者
7#
發(fā)表于 2025-3-22 18:47:52 | 只看該作者
Yoichi Mizutani M.D. oral mucosa, genital mucosa, eyes, leptomeninges, and other visceral organs may be the initial sites. It is the most common cause of death among skin diseases. It originates from the melanocytes of normal skin or from melanocytic nevi. Individuals with more than 100 melanocytic nevi are three to te
8#
發(fā)表于 2025-3-22 23:57:34 | 只看該作者
he cause of these benign tumors. Melanocytes are elements of the basal layer of the epidermis. Their increase in the epidermis causes epidermal melanocytic tumors. Melanocytic tumors also may be markers of some syndromes. Normally there are no melanocytes in the dermis. However, the presence of dend
9#
發(fā)表于 2025-3-23 03:33:47 | 只看該作者
Atsushi Arugahe cause of these benign tumors. Melanocytes are elements of the basal layer of the epidermis. Their increase in the epidermis causes epidermal melanocytic tumors. Melanocytic tumors also may be markers of some syndromes. Normally there are no melanocytes in the dermis. However, the presence of dend
10#
發(fā)表于 2025-3-23 06:01:22 | 只看該作者
Shinichiro Motohashition of these measurements in the development of therapeuticThis book presents the concepts underlying the measurement of parasympathetic and sympathetic (P&S) activity in the autonomic nervous system and the application of these measurements in the development of therapeutic guidelines for treating
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-9 12:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
枣庄市| 沧州市| 平武县| 耒阳市| 仪征市| 兴和县| 仁怀市| 武安市| 准格尔旗| 介休市| 德格县| 颍上县| 闻喜县| 尖扎县| 天全县| 耿马| 资溪县| 青河县| 九江市| 石屏县| 延津县| 防城港市| 平谷区| 宁都县| 柯坪县| 东阳市| 峨眉山市| 永清县| 利川市| 炎陵县| 保山市| 富锦市| 定南县| 岢岚县| 中山市| 马尔康县| 泾阳县| 南充市| 醴陵市| 克山县| 繁昌县|